Now, cancer vaccine from cat poop parasite

Image
IANS New York
Last Updated : Jul 18 2014 | 2:54 PM IST

You may soon look at cat poop in a different light as it may hold the key to cancer cure.

Using a parasite found in the intestines of cats, researchers have created a cancer vaccine that resulted in unprecedented high rates of cancer survival when tested in extremely aggressive lethal mouse models of melanoma and ovarian cancer.

A healthy immune system responds vigorously to T. gondii, a single-celled parasite that lives in a cat's intestines, in a manner that parallels how the immune system attacks a tumour.

"We know biologically this parasite has figured out how to stimulate the exact immune responses to fight cancer," said David Bzik, professor of microbiology and immunology at Dartmouth College in the US.

In response to T. gondii, the body produces natural killer cells and cytotoxic T cells.

Cancer can shut down the body's defensive mechanisms, but introducing T. gondii into a tumour environment can jump start the immune system.

Since it is not safe to inject a cancer patient with live replicating strains of T. gondii, the researchers created "cps" - an immunotherapeutic vaccine.

Based on the parasite's biochemical pathways, they deleted a Toxoplasma gene needed to make a building block of its genome and create a mutant parasite that can be grown in the laboratory, but is unable to reproduce in animals or people.

Cps is both non-replicating and safe. Even when the host is immune deficient, cps still retains that unique biology that stimulates the ideal vaccine responses.

"Aggressive cancers too often seem like fast moving train wrecks. Cps is the microscopic, but super strong, hero that catches the wayward trains, halts their progression, and shrinks them until they disappear," Bzik added.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 18 2014 | 2:46 PM IST

Next Story